PIM Kinases as Potential Biomarkers and Therapeutic Targets in Inflammatory Arthritides

The Proviral Integration site for the Moloney murine leukemia virus (PIM)-1 kinase and its family members (PIM-2 and PIM-3) regulate several cellular functions including survival, proliferation, and apoptosis. Recent studies showed their involvement in the pathogenesis of rheumatoid arthritis RA, wh...

Full description

Bibliographic Details
Main Authors: Elisa Assirelli, Jacopo Ciaffi, Valentina Scorcu, Susanna Naldi, Veronica Brusi, Luana Mancarella, Lucia Lisi, Federica Pignatti, Francesco Ursini, Simona Neri
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/25/6/3123
_version_ 1797240743410008064
author Elisa Assirelli
Jacopo Ciaffi
Valentina Scorcu
Susanna Naldi
Veronica Brusi
Luana Mancarella
Lucia Lisi
Federica Pignatti
Francesco Ursini
Simona Neri
author_facet Elisa Assirelli
Jacopo Ciaffi
Valentina Scorcu
Susanna Naldi
Veronica Brusi
Luana Mancarella
Lucia Lisi
Federica Pignatti
Francesco Ursini
Simona Neri
author_sort Elisa Assirelli
collection DOAJ
description The Proviral Integration site for the Moloney murine leukemia virus (PIM)-1 kinase and its family members (PIM-2 and PIM-3) regulate several cellular functions including survival, proliferation, and apoptosis. Recent studies showed their involvement in the pathogenesis of rheumatoid arthritis RA, while no studies are available on psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA). The main objective of this study is to assess the expression of PIM kinases in inflammatory arthritides, their correlation with proinflammatory cytokines, and their variation after treatment with biologic disease-modifying anti-rheumatic drugs or JAK inhibitors. We evaluated PIM-1, -2, and -3 expression at the gene and protein level, respectively, in the peripheral blood mononuclear cells and serum of patients with RA, PsA, axSpA, and healthy individuals (CTR). All the samples showed expression of PIM-1, -2, and -3 kinases both at the gene and protein level. PIM-1 was the most expressed protein, PIM-3 the least. PIM kinase levels differed between controls and disease groups, with reduced PIM-1 protein and increased PIM-3 protein in all disease samples compared to controls. No difference was found in the expression of these molecules between the three different pathologies. PIM levels were not modified after 6 months of therapy. In conclusion, our preliminary data suggest a deregulation of the PIM pathway in inflammatory arthritides. In-depth studies on the role of PIM kinases in this field are warranted.
first_indexed 2024-04-24T18:12:17Z
format Article
id doaj.art-4b082b44ca084fdfa40753955188e159
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-04-24T18:12:17Z
publishDate 2024-03-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-4b082b44ca084fdfa40753955188e1592024-03-27T13:45:05ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672024-03-01256312310.3390/ijms25063123PIM Kinases as Potential Biomarkers and Therapeutic Targets in Inflammatory ArthritidesElisa Assirelli0Jacopo Ciaffi1Valentina Scorcu2Susanna Naldi3Veronica Brusi4Luana Mancarella5Lucia Lisi6Federica Pignatti7Francesco Ursini8Simona Neri9Medicine and Rheumatology Unit, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, ItalyMedicine and Rheumatology Unit, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, ItalyMedicine and Rheumatology Unit, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, ItalyMedicine and Rheumatology Unit, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, ItalyMedicine and Rheumatology Unit, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, ItalyMedicine and Rheumatology Unit, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, ItalyMedicine and Rheumatology Unit, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, ItalyMedicine and Rheumatology Unit, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, ItalyMedicine and Rheumatology Unit, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, ItalyMedicine and Rheumatology Unit, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, ItalyThe Proviral Integration site for the Moloney murine leukemia virus (PIM)-1 kinase and its family members (PIM-2 and PIM-3) regulate several cellular functions including survival, proliferation, and apoptosis. Recent studies showed their involvement in the pathogenesis of rheumatoid arthritis RA, while no studies are available on psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA). The main objective of this study is to assess the expression of PIM kinases in inflammatory arthritides, their correlation with proinflammatory cytokines, and their variation after treatment with biologic disease-modifying anti-rheumatic drugs or JAK inhibitors. We evaluated PIM-1, -2, and -3 expression at the gene and protein level, respectively, in the peripheral blood mononuclear cells and serum of patients with RA, PsA, axSpA, and healthy individuals (CTR). All the samples showed expression of PIM-1, -2, and -3 kinases both at the gene and protein level. PIM-1 was the most expressed protein, PIM-3 the least. PIM kinase levels differed between controls and disease groups, with reduced PIM-1 protein and increased PIM-3 protein in all disease samples compared to controls. No difference was found in the expression of these molecules between the three different pathologies. PIM levels were not modified after 6 months of therapy. In conclusion, our preliminary data suggest a deregulation of the PIM pathway in inflammatory arthritides. In-depth studies on the role of PIM kinases in this field are warranted.https://www.mdpi.com/1422-0067/25/6/3123rheumatoid arthritisaxial spondyloarthritispsoriatic arthritisPIM kinases
spellingShingle Elisa Assirelli
Jacopo Ciaffi
Valentina Scorcu
Susanna Naldi
Veronica Brusi
Luana Mancarella
Lucia Lisi
Federica Pignatti
Francesco Ursini
Simona Neri
PIM Kinases as Potential Biomarkers and Therapeutic Targets in Inflammatory Arthritides
International Journal of Molecular Sciences
rheumatoid arthritis
axial spondyloarthritis
psoriatic arthritis
PIM kinases
title PIM Kinases as Potential Biomarkers and Therapeutic Targets in Inflammatory Arthritides
title_full PIM Kinases as Potential Biomarkers and Therapeutic Targets in Inflammatory Arthritides
title_fullStr PIM Kinases as Potential Biomarkers and Therapeutic Targets in Inflammatory Arthritides
title_full_unstemmed PIM Kinases as Potential Biomarkers and Therapeutic Targets in Inflammatory Arthritides
title_short PIM Kinases as Potential Biomarkers and Therapeutic Targets in Inflammatory Arthritides
title_sort pim kinases as potential biomarkers and therapeutic targets in inflammatory arthritides
topic rheumatoid arthritis
axial spondyloarthritis
psoriatic arthritis
PIM kinases
url https://www.mdpi.com/1422-0067/25/6/3123
work_keys_str_mv AT elisaassirelli pimkinasesaspotentialbiomarkersandtherapeutictargetsininflammatoryarthritides
AT jacopociaffi pimkinasesaspotentialbiomarkersandtherapeutictargetsininflammatoryarthritides
AT valentinascorcu pimkinasesaspotentialbiomarkersandtherapeutictargetsininflammatoryarthritides
AT susannanaldi pimkinasesaspotentialbiomarkersandtherapeutictargetsininflammatoryarthritides
AT veronicabrusi pimkinasesaspotentialbiomarkersandtherapeutictargetsininflammatoryarthritides
AT luanamancarella pimkinasesaspotentialbiomarkersandtherapeutictargetsininflammatoryarthritides
AT lucialisi pimkinasesaspotentialbiomarkersandtherapeutictargetsininflammatoryarthritides
AT federicapignatti pimkinasesaspotentialbiomarkersandtherapeutictargetsininflammatoryarthritides
AT francescoursini pimkinasesaspotentialbiomarkersandtherapeutictargetsininflammatoryarthritides
AT simonaneri pimkinasesaspotentialbiomarkersandtherapeutictargetsininflammatoryarthritides